baber/WOPTO huggingface dataset:
Patent MX-PA02003238-A (MX)
Title: System and method for conditioned-based monitoring of a bearing assembly.
Inventor: LARRY R HANDLER
IPC: G01M13/045
Filed: 2002-04-04
Abstract: The present invention is for a system (11) or method for conditioned bas ed monitoring of a bearing assembly. The system (11) comprises a sensor (13) placed in proximity to a bearing assembly (12). The sensor (13) generates a signal indicative of the amplitude and frequency of the vibrational movement of the bearing assembly. A process (14) in communication with the sensor (13) receives the signal from the sensor (13) and generates spectral data representative of the bearing vibrational movement. A database (15) comprises data representative of an amplitude threshold, for at least one predetermined frequency, characteristic of a bearing fault. The processor (15) compares the spectral data to the amplitude threshold and generates a signal indication of the bearing assembly.
Patent MX-PA02006882-A (MX)
Title: User interface for portable rfid reader.
Inventor: EISENBERG PETER M
IPC: G06V30/00
Filed: 2001-01-05
Abstract: A user interface for a radio frequency identification interrogation system is disclosed, which interface may include graphics, sounds, lights, or combinations of the foregoing that provide information to a user in regard to the materials being interrogated.
Patent MX-PA02007066-A (MX)
Title: Frame structure for variable rate wireless channels transmitting high speed data.
Inventor: TONG WEN
IPC: H04W28/22
Filed: 2001-01-19
Abstract: A frame structure that is optimized for providing variable high data rates. Superframes, each comprised of a predetermined number of frames, carry data communications at one or more variable data rates. Each data customer is allotted one or more frames or portions of frames within the superframe, called sub frames, as is needed to deliver the data communication. The allocation for the data customers is not fixed, but varies as the data rate varies over time, and also to meet the needs of the data customers. Each high speed data frame includes a self indication of the contents of the high speed data frame. This self indication identifies one or more data users serviced by the high speed data frame and the data rate of the data contained in the high speed data frame. Each high speed data frame may service multiple user terminals, with the high speed data frame subdivided into two or more subframes. In this case, an additional self indication may be provided to identify an intended user terminal and a corresponding data rate for the second user terminal. The frame structure may be applied to service ATM cells.
Patent MX-PA02007472-A (MX)
Title: Systems and methods for providing promotions with recorded programs.
Inventor: CORVIN JOHNNY B
IPC: H04N5/445
Filed: 2001-02-01
Abstract: The invention provides systems and methods for providing promotions with recorded programs. These systems and methods provide for selecting a program to record, selecting a promotion, recording the selected program; and recording the promotion with the program or inserting the promotion during playback of the recorded program. The invention also provides a receiver for receiving signals and or data (e.g., programs, promotions, program guides, etc.) on a single broadcast channel or on a plurality of broadcast channels, one or more memory storage units for storing signals and or data, and a processor for selecting a program, selecting a promotion, causing selected programs to be recorded, and controlling the insertion of promotions into a program during recording of the program or during playback of the program.
Patent MX-PA02010670-A (MX)
Title: New dendritic cell co stimulatory molecules.
Inventor: PARDOLL DREW M
IPC: A61K39/00
Filed: 2001-04-27
Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.
Patent MX-PA03003487-A (MX)
Title: High oil clear emulsion with elastomer.
Inventor: MATTAI JAIRAJH
IPC: A61K8/895
Filed: 2001-10-19
Abstract: A clear antiperspirant and / or deodorant composition in the form of an emulsion having a refractive index of less than 1.42 is described and comprising: (a) 25-70% of an external phase comprising: (i) 0.1-10%, on an active base, of at least one elastomer which is a cross-polymer of dimethicone / vinyl dimethicone (ii) 0.1-5% of a silicone copolyol having a lipophilic hydrophilic balance value of 8; (iii) 0.1-68 % of a volatile silicone selected in an amount to complete the external phase; (iv) 9.10% of a cosurfactant or emulsifier having a lipophilic hydrophilic balance value in the range of 1-15; (v) 0-5% of a non-volatile silicone, and (b) 30-75% of an internal phase which is made with: (I) 7-25% (on an anhydrous basis (excluding waters of hydration) of an antiperspirant active; (ii) 0- 10% ethanol, (iii) additional water as required to adjust the refractive index, (iv) 0-5% of an antimicrobial agent, and (v) 0-5% of an ionizab salt.
Patent MX-PA03004576-A (MX)
Title: Gyroscopic mass flowmeter.
Inventor: VAN CLEVE CRAIG BRAINERD
IPC: G01F1/84
Filed: 2001-11-14
Abstract: A mass flowmeter having a first embodiment (1500) that uses gyroscopic forces rather than Coriolis forces to determine material flow information, such as mass flow rates, for a material flow. The interior of the flow tube (400) defines a helix element (300) that imparts a spin to the material flow within the flow tube. The flow tube is vibrated transversely by a driver (D). The transverse vibrations and the spin imparted to the material flow together generate gyroscopic forces within the flow tube. The magnitude of the flow tube deflection that results from the gyroscopic forces is related to the magnitude of the material flow within the flowmeter and is measured to determine material flow information. A second embodiment (1600) of the flowmeter further functions to detect the Coriolis forces on the vibrating flow tube and generates material flow information from the detected Coriolis forces. The Coriolis based material flow information and the gyroscopic based material flow information are both applied to associated meter electronics which uses the two sets of information for comparison and error checking and other purposes such as compensation.
Patent MX-PA03008017-A (MX)
Title: Fault-tolerant computer cluster and a method for operating a cluster of this type.
Inventor: OLIVER KAISER
IPC: G06F11/18
Filed: 2002-02-28
Abstract: The invention relates to a computer cluster comprising a network plane (10) and a processing plane (30). In said cluster, the network plane (10) is formed by at least one network computer (11, 12, 13), which is configured to assign a time tag to incoming request data (7). The processing plane (30) is composed of at least two processing computers (201, 202, 20x, 211, 212, 21y, 221, 222, 22z), which are supplied in parallel with the request data (7) from the network plane (10). Each processing computer is configured to process the request data (7) in a subsequent processing step, if the current value of the time tag falls within a respective significant value range. An "implicit synchronisation" of the computers is thus achieved in a simple manner.
Patent MX-PA03009634-A (MX)
Title: A latent property diagnosing procedure.
Inventor: SARAH M HARTZ
IPC: G09B7/00
Filed: 2002-04-19
Abstract: A method of doing cognitive diagnosis of mental skills, medical and psychiatric diagnosis of diseases and disorders, and in general the diagnosing (1711) of latent properties of a set of objects, usually people, for which multiple pieces of binary (dichotomous) information about the objects are available, for example testing examines using right/wrong scored test questions. Settings where the present invention can be applied but are not limited to include classrooms at all levels, web-based instruction, corporate in-house training, large scale standardized tests, and medical and psychiatric settings. Uses (1713) include but are not limited to individual leaner feedback, leaner remediation, group level education assessment, and medical and psychiatric treatment.
Patent MX-PA03011161-A (MX)
Title: Topical treatments using alkanolamines.
Inventor: NICHOLAS V PERRICONE
IPC: A61Q5/02
Filed: 2002-06-06
Abstract: Skin, hair and nails are treated by topical application of compositions containing an alkanolamine such as dimethylaminoethanol to increase smoothness and surface uniformity. Application to the skin visibly decreases pore size, treats or prevents acne, diminishes or prevents cutaneous scar tissue, and/or provides a pretreatment prior to applying electrical pulses sufficient to contract subcutaneous muscles underlying the skin. Application to the hair, fingernails or toenails increases elasticity, enhances shine, and provides emolliency to keratin. Alkanolamine compositions contain at least one other adjunct ingredient such as tyrosine, lipoic acid, an alpha -hydroxy acid, or a fatty acid ester of ascorbic acid in most embodiments.
Patent MX-PA03011843-A (MX)
Title: A novel g protein-coupled receptor, gave 3.
Inventor: TAI-HE XIA
IPC: A61K48/00
Filed: 2002-06-21
Abstract: Novel GAVE3 polypeptides, proteins and nucleic acid molecules are provided. In addition to isolated, full-length GAVE3 proteins, isolated GAVE3 fusion proteins, antigenic peptides and anti-GAVE3 antibodies are taught. GAVE3, recombinant expression vectors, host cells into that the expression vectors have been introduced and non-human transgenic animals in that a GAVE3 gene has been introduced or disrupted are taught. Diagnostic, screening and therapeutic methods utilizing compositions of the invention also are provided.
Patent MX-PA03012017-A (MX)
Title: Gfci without bridge contacts and having means for automatically blocking a face opening of a protected receptacle when tripped.
Inventor: FRANTZ GERMAIN
IPC: H01H83/04
Filed: 2003-12-19
Abstract: Located within a GFCI is a movable contact bearing arm which cooperates with at least one fixed contact. When the movable arm is moved up to allow the at least one contact on the arm to close with at least one fixed contact, the GFCI is in a conducting state and current flows from a source of electricity through the closed contacts to a load and to the contacts of a receptacle. When the movable arm is moved down to open the contacts, the GFCI is in a non-conducting state and current cannot flow from the source of electricity to either the load or the receptacle contacts. In this invention, the up and down movement of the movable contact bearing arm is harnessed to move a blocking member located within the housing of the GFCI to a first position to block at least one opening of the receptacle as the movable arm is moved down or to a second position to allow the prongs of a plug to enter the openings of the receptacle as the movable arm is moved up. The downward movement of the movable contact bearing arm occurs when the GFCI goes into a non-conducting state. Resetting the GFCI by pressing in and then releasing a reset button causes the movable contact bearing arm to move up to make contact with the at least one fixed contact. As the movable arm moves up, the blocking member moves to the first or non-blocking position to allow the prongs of a plug to freely enter the openings in the face of the receptacle. GFCI's normally have two separate sets of internally located contacts known as bridge contacts where one set is used to connect a load to the source of electricity and the second set is used to connect a user accessible load to the source of electricity. The bridge contacts provide isolation between the conductors to the load and the conductors to the contacts of the GFCI receptacle when the GFCI is in a non-conducting state. In the GFCI here disclosed, the blocking member prevents the prongs of a plug from entering the receptacle when the GFCI is in a non-conduct ing state and, therefore, the need for the bridge contacts is diminished.
Patent MX-PA04002684-A (MX)
Title: Systems, methods and kits for remote genetic analysis and consultation.
Inventor: TIMOTHY JOHNSON
IPC: G16B50/40
Filed: 2002-09-18
Abstract: Methods, systems and kits for genetic testing, especially for situations in which the procurement of genetic source material occurs at a different location than the testing of the material and the interpretation of the results.
Patent MX-PA04006036-A (MX)
Title: Method for making a non-detachable microcircuit card.
Inventor: BOUVARD JER ME
IPC: B42D15/10
Filed: 2002-12-18
Abstract: invention concerns a method for mounting a microcircuit module in a card body to make the card non-detachable without damage. The method consists in fixing the module (22) in a cavity (12) of the card body (11) with a resin after adjusting the adherence of the resin (30) on the wall of the cavity (12) so that it is markedly higher than its adherence on the module (22).
Patent MX-PA04006864-A (MX)
Title: Valve mechanism.
Inventor: MIRO CATER
IPC: B05B11/00
Filed: 2004-07-15
Abstract: A valve mechanism for a pressure chamber, particularly a pumping device, with a tappet and a valve disk, in which the valve disk is attached to the tappet, is known. According to the invention the valve disk is provided on the tappet so as to be movable in relative manner between a starting and an end position. Use for media control purposes.
Patent MX-PA04007071-A (MX)
Title: Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen.
Inventor: NIGEL BUNDRED
IPC: A61P19/10
Filed: 2003-01-16
Abstract: Disclosed is a treatment of estrogen-deficiency related complaints in females that exhibit these complaints while they are on treatment with a drug which prevents the synthesis of endogenous estrogen. Such drugs are, e.g., anti-cancer drugs such as aromatase inhibitors. The invention resides in the use of tibolone, which has an unexpectedly beneficial working in this particular patient group in that it does not stimulate breast, while preventing bone loss and relieving climacteric complaints in a patient group in which this is more difficult than in any other group due to the nature of the concomittant cancer treatment (no circulating estrogen making for a higher severity of the complaints, the lack of effect on the estrogen receptor making for an increased risk associated with estrogenic breast stimulation once estrogen-like compounds are administered.
Patent MX-PA04012420-A (MX)
Title: Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders.
Inventor: EUGENE ANTHONY TEREFENKO
IPC: A61Q7/00
Filed: 2003-06-23
Abstract: The present invention provides for the use of a compound of formula (I) or formula (II) in treating skin disorders, wherein formula (I) is: and wherein R1-R5 and Q1 are defined as described herein. Specifically, methods for treating acne, hirsutism, and conditioning the skin are described. Also provided are novel PR modulators of formula (II) and uses thereof.
Patent MX-PA04012500-A (MX)
Title: Copolymers for avoiding deposits in water supply systems, production and use thereof.
Inventor: CHRISTIAN FLOCKEN
IPC: C08F220/06
Filed: 2003-06-14
Abstract: The invention relates to copolymers made from monoethylenically unsaturated monomers with acid groups and a further hydrophobic monomer component for the prevention of inorganic and organic deposits in water supply systems. The invention further relates to a method for production of the above.
Patent MX-PA04012974-A (MX)
Title: Medicinal composition for regulating release and process for producing the same.
Inventor: TOYOHIRO SAWADA
IPC: A61K9/16
Filed: 2003-12-24
Abstract: A particle size-controlling substance containing a drug, polyethylene oxide having a molecular weight of 2,000,000 or more and a particle size-controlling agent (a substance having appropriate plasticizing properties and binding force) for the polyethylene oxide wherein at least the particle size-controlling agent as specified above is uniformly dispersed in the polyethylene oxide; a medicinal composition for regulating release which contains the particle size-controlling substance; and a process for producing the medicinal composition for regulating release which contains the particle size-controlling substance. By using polyethylene oxide powder/grains in which the specific particle size-controlling agent for polyethylene oxide is uniformly dispersed and which have powder characteristics appropriate for tabletting, a medicinal composition for regulating release showing favorable content uniformity can be provided.
Patent MX-PA05001690-A (MX)
Title: Screening strategy for anticancer drugs.
Inventor: BROUDE EUGENIA
IPC: A61K6/00
Filed: 2003-08-13
Abstract: The invention provides methods and reagents for identifying compounds that growth inhibit or kill tumor cells.
Patent MX-PA05001816-A (MX)
Title: Durable emi shielding film.
Inventor: BRIGHT CLARK I
IPC: B32B15/08
Filed: 2003-08-15
Abstract: A device or an enclosed area that can cause or is sensitive to electromagnetic interference (EMI) is shielded by at least partially surrounding the device or the area with a visible light-transmissive film comprising a flexible support, an extensible visible light-transmissive metal or metal alloy layer and a visible light-transmissive crosslinked polymeric protective layer, and optionally connecting at least one grounding electrode to the metal or metal alloy layer. The film has reduced susceptibility to fracture or corrosion compared to commercially available EMI shielding films, especially when bent or deformed.
Patent MX-PA05002932-A (MX)
Title: Removable, water-whitening resistant pressure sensitive adhesives.
Inventor: CHEN AUGUSTIN T
IPC: C08F8/30
Filed: 2003-09-25
Abstract: Removable pressure sensitive adhesive compositions having enhanced resistance to water-whitening comprising a crosslinked aqueous emulsion polymer are disclosed. The crosslinked aqueous emulsion polymer comprises (a) at least one hydrophobic monomer; (b) greater than 1wt.% of at least one hydrophilic monomer; (c) greater than 3w.% of at least one mono-olefinically unsaturated monomer having an aldehyde or ketone group; (d) optionally at least one partially hydrophilic monomer; and (e) an effective amount of at least one water-soluble or water-dispersible polymerizable surfactant; wherein the crosslinked aqueous emulsion polymer is crosslinked with an effective amount of at least one polyhydrazide crosslinker, the wt.% of monomers (a), (b), (c) and (d) are based on the total weight of monomers (a), (b), (c) and (d), and the mean particle size of the crosslinked aqueous emulsion polymer is less than about 400.
Patent MX-PA05005547-A (MX)
Title: Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents.
Inventor: GARY PHILLIPS
IPC: C07D413/12
Filed: 2003-11-28
Abstract: This invention relates to pyrimidine derivatives of general formula (I) as inhibitors of kinases, their production as well as their use as medications for treating various diseases.
Patent MX-PA05010601-A (MX)
Title: Method and apparatus for oil water separation.
Inventor: BENACHENHOU AMINE
IPC: B01D17/025
Filed: 2003-04-01
Abstract: A method and apparatus for separating immiscible liquids in a dispersion containing an aqueous liquid and at least one dispersed non-aqueous liquid by passing the dispersion through a series of absorbents, preferably polymeric. The direction of the flow through the absorbent is periodically changed. The period required before a change of the flow direction is established by the differential pressure. There is a gradual increase in the differential pressure across the absorbents which indicates a blockage due to viscous oil and/or solids. The product produced by the method and the apparatus of the invention is a polished non-aqueous phase and a polished aqueous phase both having low contaminant levels. In a preferred embodiment when solids are also present in the dispersion, a solids stream is also recovered.
Patent MX-PA05011124-A (MX)
Title: Polymethylmethacrylate compositions of enhanced optics and low temperature impact strength.
Inventor: HAFNER BIRGIT
IPC: A61K8/49
Filed: 2002-02-06
Abstract: Acrylic based multipolymer compositions having enhanced optical properties, comparable to impact modified PMMA resins, good sub-zero temperature impact strength similar to that of the Acrylic Based Multipolymer Compounds and improved weatherability, are disclosed. These compositions comprise a blend of an acrylic based multipolymer, comprising one or more of acrylonitrile, butyl acrylate, ethyl acrylate, methyl acrylate, methyl methacrylate, and styrene; a methylmethacrylate-butadiene-styrene (MBS) copolymer modifier polymerized by a free radical process; UV stabilizers, including benzotriazole derivatives, triazine derivatives, and hindered amine light stabilizers, as single components or combinations thereof; and one or more antioxidants, dyes and plasticizing flow enhancers. Both the compositions and their method of preparation are disclosed. The compositions are particularly useful for injection molding applications and the preparation of polymer films and sheets having improved optical and thermal properties, that are particularly suited for a variety of industrial applications.
Patent MX-PA06003136-A (MX)
Title: Hair care composition.
Inventor: VAN-VUURE AART
IPC: A61K8/39
Filed: 2004-08-27
Abstract: i) an aqueous lamellar phase comprising a) cationic surfactant and b) fatty alcohol having a melting point greater than 35oC and/or fatty acid having a melting point greater than 40 oC; and ii) 20 wt% or greater of one or more non-volatile liquid emollient(s), the viscosity of any single non-volatile emollient or the viscosity of a blend of non-volatile emollients being less than 1000 mPa.s at 35oC and 5 s-1.
Patent MX-PA06003569-A (MX)
Title: Nickel-base alloys and methods of heat treating nickel-base alloys.
Inventor: KENNEDY RICHARD L
IPC: C22C19/05
Filed: 2004-09-28
Abstract: Embodiments of the present invention relate to nickel-base alloys, and in particular 718-type nickel-base alloys, having a desired microstructure that is predominantly strengthened by gamma'-phase precipitates and comprises an amount of at least one grain boundary precipitate. Other embodiments of the present invention relate to methods of heat treating nickel-base alloys, and in particular 718-type nickel-base alloys, to develop a desired microstructure that can impart thermally stable mechanical properties. Articles of manufacture using the nickel-base alloys and methods of heat treating nickel-base alloys according to embodiments of the present invention are also disclosed.
Patent MX-PA06005639-A (MX)
Title: The use of anti biotics as vaccine adjuvants.
Inventor: LEYH RANDY DEAN
IPC: A61K39/116
Filed: 2004-11-08
Abstract: The invention describes an adjuvant composition comprising an antimicrobial agent, in particular an azalide, wherein the antimicrobial agent acts as an adjuvant. More particularly, the adjuvant composition is a vaccine adjuvant. The invention further describes a vaccine comprising several components comprising (a) at least one antigen and (b) at least one antimicrobial agent, in particular an azalide, wherein the azalide acts as an adjuvant. An adjuvant composition or vaccine of the present invention is useful in the prevention and treatment of diseases caused by a pathogenic agent, a cancerous cell, or an allergen.